Tocqueville Asset Management L.P. Abbott Laboratories Transaction History

Tocqueville Asset Management L.P.

$6.05 Billion
Q1 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 199,428 shares of ABT stock, worth $20.7 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

199,428

Previous 324,145 38.48%

Holding current value

$20.7 Million

Previous $35.7 Million 36.47%

% of portfolio

0.37%

Previous 0.65%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $13.7 Million - $15.1 Million	-124,717 Reduced 38.48%	199,428 $22.7 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $2.94 Million - $3.6 Million	-32,630 Reduced 9.15%	324,145 $35.7 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $1.86 Million - $2.23 Million	-19,440 Reduced 5.17%	356,775 $34.6 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.46 Million - $1.62 Million	-14,454 Reduced 3.7%	376,215 $41 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $232,076 - $273,167	-2,396 Reduced 0.61%	390,669 $39.6 Million

Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $850,787 - $998,104	8,950 Added 2.33%	393,065 $43.2 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $9,192 - $10,642	95 Added 0.02%	384,115 $37.2 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $20,414 - $24,674	-200 Reduced 0.05%	384,020 $41.7 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $258,255 - $314,925	-2,265 Reduced 0.59%	384,220 $45.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $248,505 - $304,280	2,151 Added 0.56%	386,485 $54.4 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $10.9 Million - $12 Million	93,265 Added 32.04%	384,334 $45.4 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $186,613 - $219,670	1,764 Added 0.61%	291,069 $33.7 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $115,588 - $136,180	-1,062 Reduced 0.37%	289,305 $34.7 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $20,475 - $22,311	-195 Reduced 0.07%	290,367 $31.8 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $2.11 Million - $2.57 Million	-23,068 Reduced 7.36%	290,562 $31.6 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $2.61 Million - $3.34 Million	-34,121 Reduced 9.81%	313,630 $28.7 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.29 Million - $1.88 Million	-20,520 Reduced 5.57%	347,751 $27.4 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $764,844 - $851,450	-9,742 Reduced 2.58%	368,271 $32 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $1.39 Million - $1.51 Million	-16,999 Reduced 4.3%	378,013 $31.6 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $329,854 - $384,710	-4,526 Reduced 1.13%	395,012 $33.2 Million
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $2.13 Million - $2.58 Million	-32,173 Reduced 7.45%	399,538 $31.9 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $1.03 Million - $1.17 Million	-15,785 Reduced 3.53%	431,711 $31.2 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $1.89 Million - $2.28 Million	-31,047 Reduced 6.49%	447,496 $32.8 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $8.24 Million - $9.1 Million	-143,214 Reduced 23.03%	478,543 $29.2 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $9.04 Million - $10.2 Million	-160,587 Reduced 20.53%	621,757 $37.3 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $8.41 Million - $9 Million	-156,607 Reduced 16.68%	782,344 $44.6 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $45.1 Million - $50.4 Million	938,951	938,951 $50.1 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Abbott Laboratories Transaction History